ACHV News and Press, Achieve Life Sciences Inc. From 06/29/20

SEATTLE and VANCOUVER, BC , June 29, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announce...

Achieve Announces Successful Results from the Investigator-Initiated RAUORA Head-to-Head Non-Inferiority Clinical Trial Comparing Cytisinicline and Chantix® (varenicline) as a Treatment to Quit Smoking Canada NewsWire SEATTLE and VANCOUVER, BC, June 29, 2020 Cytisinic...

Achieve Life Sciences, Inc. (ACHV) Q1 2020 Results Earnings Conference Call May 14, 2020, 08:00 AM ET Company Participants Jaime Xinos - Executive Vice President of Commercial Richard Stewart - Chief Executive Officer John Bencich - Chief Financial Officer and Operating Officer ...

Achieve Life Sciences (NASDAQ: ACHV ) provides an update on the cytisinicline clinical development program. More news on: Achieve Life Sciences, Inc., Healthcare stocks news, Read more ...

Achieve Life Sciences (NASDAQ: ACHV ): Q1 GAAP EPS of -$0.11 beats by $0.01 . More news on: Achieve Life Sciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

Achieve Reports Financial Results for First Quarter 2020 and Provides Update on Cytisinicline Development Program Canada NewsWire SEATTLE and VANCOUVER, British Columbia, May 14, 2020 SEATTLE and VANCOUVER, British Columbia , May 14, 2020 /CNW/ -- Achieve Life Sciences,...

SEATTLE and VANCOUVER, British Columbia , May 5, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addic...

Achieve Life Sciences (NASDAQ: ACHV ) has entered into definitive agreements for a private placement of 5,615,653 units at $0.33/unit, with each unit consisting of one common share and a warrant to purchase 0.75 shares of common stock, for gross proceeds of ~$1.9M. More news on: Ach...

Achieve Life Sciences Announces Private Placement of $1.9 Million Canada NewsWire SEATTLE and VANCOUVER, British Columbia, April 30, 2020 SEATTLE and VANCOUVER, British Columbia , April 30, 2020 /CNW/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharm...

- Will support Sera’s Transition from clinical to commercial stage company - - Sera positioned for growth with several outcome study read-outs taking place in 2020 - SALT LAKE CITY, April 02, 2020 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., The Pregnancy Company...